Healthcare, E-Commerce And Global Markets Will Fuel Long-Term Success

Published
16 Sep 24
Updated
14 Aug 25
AnalystConsensusTarget's Fair Value
US$6.42
7.9% overvalued intrinsic discount
14 Aug
US$6.93
Loading
1Y
17.5%
7D
10.5%

Author's Valuation

US$6.4

7.9% overvalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on08 Aug 25
Fair value Increased 32%

The notable upward revision in FIGS' fair value reflects improved consensus revenue growth expectations, more than offsetting the impact of a higher discount rate, resulting in an increased analyst price target from $4.86 to $5.85. What's in the News FIGS, Inc.

Shared on01 May 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on23 Apr 25
Fair value Decreased 2.99%

AnalystConsensusTarget has decreased revenue growth from 3.0% to 2.6%.

Shared on17 Apr 25
Fair value Increased 10%

AnalystConsensusTarget has increased revenue growth from 2.1% to 3.0%, increased profit margin from 3.6% to 4.9% and decreased future PE multiple from 37.5x to 29.3x.

Shared on09 Apr 25
Fair value Decreased 14%

AnalystConsensusTarget has decreased revenue growth from 3.0% to 2.1%, decreased profit margin from 4.9% to 3.6% and increased future PE multiple from 31.0x to 37.5x.

Shared on02 Apr 25
Fair value Increased 0.95%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on26 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on19 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on11 Mar 25
Fair value Increased 15%

AnalystConsensusTarget has decreased revenue growth from 3.9% to 3.0%, increased profit margin from 4.2% to 4.9% and decreased future PE multiple from 45.8x to 31.0x.